Inefficient trafficking of recombinant adeno-associated virus type-2 (rAAV2) to the nucleus is a major barrier for transduction. Using imaging and subcellular fractionation techniques, we evaluated the extent of rAAV2 movement through the late (Rab7) and recycling (Rab11) endosomes. Following rAAV2 infection of HeLa cells, immunoisolation of HA-Rab7-or HA-Rab11-tagged endosomes and intracellular colocalization of Cy3-labeled rAAV2 with EGFP-Rab7 or EGFPRab11 markers demonstrated dose-dependent trafficking of rAAV2 through the recycling and late endosomal compartments. At low multiplicities of infection (m.o.i. 100 genomes/cell), rAAV2 predominantly trafficked to the Rab7 compartment. In contrast, rAAV2 predominantly trafficked to the recycling endosome at 100-fold higher m.o.i. siRNA studies inhibiting either Rab7 or Rab11 demonstrated that reducing Rab11 protein levels more significantly inhibited rAAV2 transduction on a per genome basis compared to inhibition of Rab7. Dose-response curves, comparing the m.o.i. of AV2Luc infection to relative transduction, also supported the hypothesis that viral movement through the Rab11 compartment at high m.o.i. is more competent for transgene expression (~100-fold) than virus that moves through the Rab7 compartment at low m.o.i. These findings suggest that strategies to shunt viral movement from the late to the recycling endosome may be effective at increasing viral transduction for gene therapy.
INTRODUCTION
Recombinant adeno-associated virus (rAAV) has moved to the forefront of human gene therapy as one of the more widely studied and promising gene delivery vectors. However, increasing evidence has indicated that intracellular trafficking of rAAV2 to the nucleus is a slow, ratelimiting, process for certain cell types [1] [2] [3] [4] . Other studies have also suggested that rAAV uncoating may also be rate limiting [4] and influenced by endosomal processing and/or ubiquitination of the viral capsid [5, 6] . Studies evaluating the subcellular distribution of rAAV2 following infection remain ambiguous and sometimes controversial [7] [8] [9] [10] . Canine parvovirus and rAAV2 are endocytosed through clathrin-dependent receptor-mediated endocytosis and are processed through endosomal compartments in a fashion similar to that of transferrin [7, 8, 11, 12] . Although it has yet to be evaluated directly for AAV2, transferrin traffics through the early endosome to the perinuclear recycling endosome (PNRE) [13, 14] . Hence the PNRE has been considered indirectly as one compartment into which rAAV2 traffics. However, based on pharmacologic and biochemical subcellular fractionation approaches, other reports have suggested that rAAV2 may traffic through the late endosome to the lysosome [9, 15] or may exit very early from the early endosome [8, 16] . Consequently, the process of rAAV2 movement within cells remains controversial.
Since various vesicular compartments differ in size, shape, and density, one popular method for evaluating AAV movement within cells has been the physical separation of different endosomal compartments using gradient centrifugation. However, since physical properties of different vesicular compartments significantly overlap, this separation method is not always satisfactory. In the present study, we sought to utilize tagged Rab proteins as markers for the isolation and localization of rAAV2 within the two major compartments currently hypothesized to process this serotype (i.e., the late endosome and the PNRE). Over the past 2 decades, Rab proteins have been discovered that specifically demarcate certain intracellular compartments [17] . The Rab family is, so far, the largest branch of the Ras superfamily. More than 60 members have been found in mammalian cells. Through the temporal control of the binding of corresponding effectors, individual Rab proteins are involved in multiple events, such as vesicle budding, vesicular movement, membrane tethering/docking, and membrane fusion [18] . Our study focused on Rab7 and Rab11, which are involved in distinct intracellular pathways. Rab7 is regarded as a specific marker for late endosomes and has been shown to be essential for lysosome biogenesis [19] . Rab11 is primarily localized on the PNRE [14] , which has been shown to be inaccessible to ligands and receptors destined for lysosomal degradation through the Rab7 late endosome compartment. Rab11 has been extensively studied for its involvement in transferrin receptor recycling [2, 20] . The activation of Rab11 is required for the entrance of transferrin into the PNRE and for the direct recycling of transferrin from the PNRE to the cell surface. N-terminus fusions to both Rab7 and Rab11 do not change their intracellular distribution patterns, and there is no significant alteration of the biological activities of these Rab fusions in recruiting their effectors, compared to the wild-type forms [13] . To this end, in the current study we have utilized HA-Rab and EGFP-Rab fusions as highly specific tags to study the intracellular trafficking patterns of rAAV2.
We have focused here on delineating the extent to which rAAV2 traffics through the Rab7 late endosome and Rab11 PNRE in HeLa cells. Using an immunoisolation procedure, we have found that the extent of viral trafficking through each of these compartments was significantly affected by the amount of virus that entered the cell. At an effective m.o.i. of 100 genomes/cell, rAAV2 preferentially partitioned to the Rab7 compartment~100-fold more effectively than to the Rab11 compartment. In contrast, at an effective m.o.i. of 10,000 genomes/cell, rAAV2 preferentially partitioned to the Rab11 compartment 17-fold more effectively than to the Rab7 compartment. These data, together with colocalization studies with EGFPtagged RabTs and Cy3-AAV, suggest that rAAV2 can dynamically traffic through both Rab7 and Rab11 compartments in a dose-dependent fashion. Studies using siRNA to inhibit trafficking through the Rab7 and Rab11 compartments aided in dissecting which of these two pathways were most functionally relevant to rAAV2 functional transduction (i.e., expression of an encoded transgene). Although siRNA's to Rab7 and Rab11 both inhibited transduction with rAAV2, on a per viral genome basis, trafficking through the Rab11 compartment was~100-fold more efficient at processing virus to functional expression of an encoded transgene. Implications of these studies suggest that altering intracellular trafficking of rAAV2 from the late to the recycling endosome may enhance the efficacy of rAAV2 vectors for gene therapy.
RESULTS

Biochemical Quantification of rAAV2 in Rab7 and Rab11 Endosomal Compartments
To characterize the distribution of rAAV2 particles in the Rab7 and Rab11 endosomal compartments, we first sought to establish several key parameters of the vesicular isolation procedure based on differential density centrifugation. We infected HeLa cells with 1 Â 10 4 DNaseresistant particles/cell for 60 min at 48C to prebind virus, followed by a 30-min incubation at 378C in the continued presence of virus. We then prepared the postnuclear supernatant (PNS) and bottom-loaded it onto an iodixanol step gradient for separation. We collected a total of 11 fractions from the top to the bottom of the gradient and measured the density of each collected fraction with a refractometer. As shown in Figs. 1A and 1B, HeLa cell PNS separated on iodixanol gradients gave rise to a peak of hglucosaminidase activity (an enzymatic marker for late endosomes) in fractions (Fr) 2-4 at a density of 1.12 g/ml. Approximately 50% of the h-glucosaminidase activity was seen in the free cytoplasmic fractions at the bottom of the tube (Fr 9-11), suggesting that approximately half of the endosomes ruptured to release this intraendosomal enzyme during the isolation.
We next sought to determine the percentage of virus that was retained in the intact endosomal fraction following our infection conditions. To this end, we quantified the rAAV2 genome copy number in each collected fraction using TaqMan-PCR (Fig. 1C) . We observed two prominent viral peaks in fractions 2-4 and 8-11, coincident with the peaks in h-glucosaminidase activity. Since isolations were performed at 30 min following infection (a relatively early time point thought to precede viral endosomal escape), and the profile of viral genomes correlated with hglucosaminidase activity, we anticipated that the peak of virus in fractions 8-11 represents free cytoplasmic virus released by preparative lysis of endosomes. To determine the distribution of free virus within the gradient and to rule out nonspecific adherence of free virus to the outside of endosomal compartments, we performed a reconstitution experiment. To this end, we mixed PNS from uninfected HeLa cells with purified rAAV2 prior to separation on an iodixanol gradient. The analysis of fractions revealed that free virus did indeed distribute within the cytoplasmic peak at the bottom of the tube and did not nonspecifically associate with endosomes during the isolation (Fig. 1D) .
As further evidence that the isolated endosomal fractions were intact, we assessed the retention of loaded biotin-transferrin in the isolated peak endosomal fractions. These studies demonstrated a dominant transferrin peak coincident with the endosomal viral genomes (Fig.  1E, Fr 2-4) . However, we observed near-equal amounts of biotin-transferrin in the free cytoplasmic fractions (9) (10) (11) , suggesting a similar level of endosomal lysis (~50%) as seen by h-glucosaminidase activity assays. These findings emphasize the difficulties in assessing viral escape from the endosome using this biochemical separation approach. However, our analysis suggests that viral genomes associated with the endosomal fractions following infection are indeed contained within the endosome. As anticipated, the endosomal transferrin peak overlapped with Rab11 immunoreactivity (a marker for recycling endosomes), since this cargo traffics through the Rab11 compartment. However, the isolation strategy was insufficient to separate Rab7 from Rab11 endosomes (Fig. 1E) , prompting us to explore other methods of endosomal preparation.
As an alternative approach to separating Rab7 from Rab11 endosomes, we sought to develop a method for immunoisolation of intact endosomes using these two proteins as membrane-anchored tags. Unfortunately, the commercially available antibodies to both Rab7 and Rab11 were unacceptable for this isolation protocol due to their insufficient affinities and/or specificities. Therefore, we generated two recombinant Rab7 and Rab11 expression plasmids that encoded hemagglutinin (HA) tags fused to the N-terminus fusions of each Rab. Previous studies have demonstrated that N-terminus fusion proteins to both Rab7 and Rab11 do not alter intracellular distribution or biological activities of these RabTs compared to the wildtype forms [13] . We transfected our HA-Rab-expressing plasmids into HeLa cells prior to iodixanol gradient separation of crude endosomal fractions containing Rab7 and Rab11. We then used this crude endosomal fraction for immunoisolation with anti-HA bound magnetic beads. The results of this immunoisolation procedure are summarized in Fig. 2 . We estimated the efficiency of transfection with an EGFP-expressing plasmid, and it was approximately 70-80%. As shown in Fig. 2A , transfected HA-Rab7 incorporated into the peak crude vesicular fraction from iodixanol gradients with an efficiency similar to that of total Rab7 (compare HA and Rab7 immunoreactivity in the PNS to iodixanol Fr 2-4). Isolation of HA-Rab7-bound endosomes from the iodixanol Fr 2-4 led to~75% recovery of HA-Rab7 and 50% recovery of total Rab7 endosomes in the bound (B) fraction following anti-HA magnetic bead isolation. Approximately 50% of the Rab7 immunoreactivity remained in the unbound (UB) fraction, suggesting that the total efficiency of isolating Rab7 endosomes from the PNS (accounting for the efficiency of transfection/HA-Rab7 expression on late endosomes and the efficiency of the HA isolation procedure) was approximately 50%. Given the approximately 75% transfection efficiency and 75% HAisolation efficiency, these estimates are well within the expected parameters of the strategy. Importantly, the purity of this isolation was very high, demonstrating no detectable immunoreactivity to Rab11 in the bound HARab7 fraction. We obtained similar findings when HARab11 endosomes were immunoaffinity isolated (Fig. 2B ).
The efficiency of HA-Rab11 endosomal isolation was approximately 75%, and the level of purification from Rab7 endosomes was very high. In summary, we have developed immunoisolation methods capable of separating Rab7 from Rab11 endosomes with high purity.
Having established methods for isolating HA-Rab7 and HA-Rab11 endosomal populations with high purity, we next sought to compare the distribution of AAV2 in these two compartments using HeLa cells transfected with HARab7 or HA-Rab11 expression plasmids prior to rAAV2 infection. Since we were unclear how much virus would be contained within either compartment, we decided to attempt these studies at two m.o.i. to ensure that TaqMan-PCR assays for viral genomes would be within the linear ranges of sensitivity (N1000 genomes for our assay). Interestingly, we observed that the extent of rAAV2 accumulation in the Rab7 and Rab11 endosomal compartment at 30 min postinfection varied significantly when cells were infected with 100 or 10,000 viral genomes/cell. As shown in Fig. 3A , at an infection efficiency of 100 genomes/ cell, significantly more rAAV2 was observed in the HARab7 bound fraction compared to the HA-Rab11 bound fraction. In the HA-Rab7 bound fraction, we recovered approximately 2.6% of viral genomes from the combined peak endosomal fraction 2-4. In contrast, the HA-Rab11 bound fraction contained only 0.02% of viral genomes in the combined endosomal fraction. This represented añ 100 fold higher level of trafficking to the Rab7, compared to the Rab11, compartment. Given the~50% efficiency of immunoisolation of the Rab7 compartment ( Fig. 2A) , we estimate that approximately 5.2% of genomes resided in the Rab7 compartment at the time of isolation. Surprisingly, at an effective m.o.i. of 10,000 viral genomes/cell, the majority of rAAV accumulated in the Rab11 compartment. At this higher m.o.i., 2.5% of viral genomes in the peak combined endosomal fraction were immunoisolated in the HA-Rab11 bound fraction, whereas only 0.15% of viral genomes resided in the HA-Rab7 fraction. Given thẽ 25% efficiency of immunoisolation of the Rab11 compartment ( Fig. 2B ), we estimate that approximately 10% of genomes resided in the combined Rab11 compartments at the time of isolation. These findings suggested that rAAV2 trafficking through the Rab7 compartment was preferred~100-fold over trafficking through the Rab11 compartment at low m.o.i. In contrast, at higher m.o.i., movement of rAAV2 through the Rab7 compartment saturated, and virus preferentially trafficked through the Rab11 compartment approximately 17-fold more effectively than the Rab7. In summary, with the change of low to high m.o.i., the fraction of virus that moves through the Rab11 compartment increased N100-fold.
Morphologic Quantification of rAAV2 in Rab7 and Rab11 Endosomal Compartments
Having biochemically demonstrated that rAAV2 movement through the Rab7 and Rab11 compartments was
Immunoisolation of Rab7 and Rab11 endosomes using ectopically expressed HA-tagged Rab's. HeLa cells were transfected with (A) HA-Rab7 or (B) HA-Rab11 expression plasmids and PNS was generated at 48 h posttransfection. The PNS was then separated on iodixanol gradients and the peak endosomal fractions (2-4) were combined and subjected to immunoisolation with HA-antibody-coated magnetic Dynabeads. Western blots for HA, Rab7, and Rab11 were performed to assess the purity and recovery of each HA-Rab compartment. PNS, postnuclear supernatant loaded onto iodixanol gradients; F2-4, the combined peak endosomal fractions used for immunoisolation; B, endosomal fraction bound to HA-antibody-coated magnetic Dynabeads; UB, unbound fraction that was not absorbed to HAantibody-coated magnetic Dynabeads. An equal percentage of each sample was loaded in each lane following concentration of endomembranes by centrifugation at 100,000g for 1 h.
dynamically affected by titer of infection, we next sought to confirm this finding using an alternative technique. To approach this question, we expressed EGFP-Rab7 and EGFP-Rab11 fusion proteins in HeLa cells to demarcate the two compartments and evaluated the extent of colocalization with Cy3-rAAV2 following infection at the two m.o.i. EGFP-tagged Rab fusion proteins have been previously used effectively to characterize the intracellular distribution of endocytic cargo [13, 19] . We transfected HeLa cells with EGFP-Rab7 or EGFP-Rab11 expression plasmids 24 h prior to infection with Cy3-labeled AV2Luc at both 100 and 10,000 genomes/cell for 30 min. Results from this analysis confirmed biochemical findings following immunoisolation of these endosomal compartments (Fig. 4) . At an m.o.i. of 100 genomes/cell, Cy3-rAAV2 predominantly colocalized with the EGFPRab7 compartment (Figs. 4A and 4C ). In contrast, at an m.o.i. of 10,000 genomes/cell, the majority of Cy3-rAAV2 overlapped with the EGFP-Rab11 compartment (Figs. 4B and 4C), and we observed little change in the amount of Cy3-rAAV2 in the EGFP-Rab7 compartment at the two m.o.i. The increase in EGFP-Rab11 colocalized Cy3-rAAV2 between the low and the high m.o.i. (5.4-fold) was not as large as that seen following biochemical isolation (~100-fold). However, we assume that this reflects both increased cotrafficking of viruses in the same endosome at the higher m.o.i. and the differences in endpoints quantified (viral genomes vs number of endosomes).
Functional Requirements for Rab7 and Rab11 in rAAV2 Transduction
Having demonstrated that rAAV2 can traffic through both the Rab7 and the Rab11 compartments in a dosedependent fashion, one of the most important questions that arises is the extent to which each of these compartments participates in functional transduction by rAAV2. To investigate further whether Rab7 and/or Rab11 endosomal pathways were functionally important for rAAV2 transduction in HeLa cells, we used siRNA approaches to inhibit Rab7 or Rab11. We hypothesized that this strategy might help determine which of these two compartments was most functionally important in the processing of rAAV2 and transduction. To develop this siRNA approach, we first compared the ability of Rab7-and Rab11-specific siRNA's to inhibit Rab protein expression compared to a scrambled siRNA control. To this end, we transfected HeLa cells with each of these siRNA's and performed Western blot analysis to determine the level of inhibition for each targeted Rab protein at 30 h posttransfection (Fig. 5A) . Transfection with Rab11 siRNA effectively reduced only Rab11 protein levels in comparison to transfection with a scrambled siRNA control. We observed no changes in Rab7 or h-actin protein levels following Rab11 siRNA transfection. Similarly, transfection with Rab7 siRNA effectively reduced only Rab7 protein levels, but not Rab11 or h-actin protein levels. We performed quantitative assessment of Rab siRNA effectiveness using infrared-conjugated secondary antibodies and a Western blot image analysis system (Odyssey 2; Li-cor Bioscience, Inc.) and referenced it to the level of h-actin immunoreactivity in each sample. As shown in To assess the functional involvement of Rab7 and Rab11 in rAAV2 transduction, we infected siRNA-transfected HeLa cells with AV2Luc at an m.o.i. of 100 genomes/cell for 24 h. We determined the relative luciferase activity for each Rab siRNA transfection group and then normalized it to the level of gene expression in the scrambled siRNA-transfected samples. Data from three independent experiments are summarized in Fig.  5C . Rab11 siRNA transfection led to 64% inhibition of rAAV2 transduction of HeLa cells, compared to Rab7 siRNA, which reduced rAAV2 transduction by 50%. Given that we saw near-equivalent levels of inhibition by these two Rab siRNA's, we conclude that both compartments are functionally involved in rAAV transduction. However, because at this low m.o.i. approximately 100-fold more virus resides in the Rab7 compartment, we conclude that the Rab11 compartment likely contributes to functional rAAV transduction to a larger extent than the Rab7 compartment.
To exclude the possibility that Rab7 and Rab11 siRNA's influence transduction indirectly by altering receptor abundance on the cell surface, we assessed viral binding and uptake in cells treated with the various siRNA's using TaqMan-PCR analysis of viral genomes. As shown in Fig.  5D , both viral binding at 48C for 1 h and uptake of virus following a 30-min 378C chase were unaffected by transfection with scrambled, Rab7, or Rab11 siRNA's. These studies indicate that expression of Rab7 or Rab11 siRNA's does not likely reduce viral transduction by altering receptor abundance or internalization of the virus.
Using an alternative approach, we sought to determine if we could alter rAAV2 transduction by overexpressing wild-type (wt) Rab7 and Rab11. As shown in Fig. 5E , overexpression of wtRab7 significantly decreased rAAV2 transduction by 50% at an m.o.i. of 100 genomes/cell. Since transfection efficiencies were approximately 50% in these studies, the level of inhibition is likely an underestimate. Given that overexpression of Rab7 is known to enhance antigen processing through the late endosome [23] , these findings support the notion that the Rab7 compartment may be less suited to productive processing of rAAV virions for competent transduction. In contrast, at the higher m.o.i. of 10,000 genomes/cell, Rab7 overexpression had little effect on rAAV2 transduction. This finding is consistent with the fact that the majority of virus does not traffic through the Rab7 compartment at this higher m.o.i. In contrast to studies with Rab7, there was no significant change in transduction at low m.o.i. when Rab11 was overexpressed in cells prior to rAAV2 transduction. However, at higher m.o.i. of infection, Rab11 overexpression led to a twofold increase in rAAV2 transduction. These findings are also consistent with the fact that significantly more virus traffics through the Rab11 compartment at higher m.o.i. of infection.
Nonlinear rAAV2 Transduction at Increasing Titers of Infection Correlates with Dose-Dependent Movement of Virus Through the Rab7 and Rab11 Compartments
Our findings suggest that rAAV2 can dynamically move through the Rab7 and Rab11 compartments in a dosedependent fashion. Furthermore, siRNA studies suggest that the Rab11 compartment may more effectively process rAAV2 genomes to a transgene-expressible state. To understand better how m.o.i.-dependent changes in rAAV2 trafficking affect transgene expression, we performed a simple dose titration of AV2Luc on HeLa cells and assessed luciferase transgene expression at increasing m.o.i. of vector. Results from these experiments are shown in Fig. 6 and demonstrate two independent linear rates of transgene expression between 0.05 to 100 and 100 to 100,000 particles/cell. The inflection point for these linear profiles of transgene expression occurred at the dose of virus that led to a change from Rab7 to Rab11 trafficking. Doses of virus required to facilitate Rab11 trafficking had a much higher capacity to process virus functionally to express transgene and began to saturate at m.o.i. greater than 100,000 particles/cell. From these data, we conclude that changes in the dose-dependent trafficking of rAAV2 through the Rab7 and Rab11 compartments are reflected by alterations in the kinetics of transgene expression.
DISCUSSION
We have attempted to use multiple complementary techniques with Rab-specific effectors as tools to elucidate the endosomal pathways through which rAAV2 moves and to determine the functional significance of these pathways in transduction. Our studies using ectopically expressed HA-Rab7 and HA-Rab11 to immunoaffinity isolate these two intracellular compartments have demonstrated that rAAV2 can dynamically move through late (Rab7) and recycling (Rab11) endosomes in a dosedependent fashion. Such findings help to explain how previous studies obtained seemingly conflicting results about rAAV2 movement through the cell. For example, several studies have implicated the late endosome as the primary pathway for rAAV2 transduction in HeLa cells [8, 9] and primary fibroblasts [15] . Others have suggested that rAAV2 traffics through the Golgi [10] or the recycling endosome with transferrin [7, 12] , a finding consistent with canine parvovirus [11] . Our current studies have added another level of complexity to interpreting these previous results by demonstrating that rAAV2 has the capacity to move through both late endosomes and recycling endosomes dynamically in a dose-dependent fashion.
Using imaging and immunoisolation strategies, we obtained data that suggest that rAAV2 preferentially moves through the Rab7 compartment at low m.o.i. In contrast, both of these assays suggest that rAAV2 movement through the Rab7 endosomal compartment saturates at higher m.o.i., giving rise to preferential trafficking to the Rab11 recycling endosomes. The mechanism of this dose-dependent change in trafficking is currently unclear, but it could involve either intracellular shunting of virus or the binding of virus to two different receptors that are targeted to the two different intracellular compartments (Fig. 7) . In the latter scenario, the binding of rAAV2 to a low-abundance, high-affinity receptor might target the virus to the late endosome. Once this high-affinity receptor is saturated at high m.o.i., the virus may utilize a lower affinity receptor that preferentially traffics to the recycling Rab11 endosome. Regardless of the mechanism of dose-dependent trafficking, these data demonstrate that rAAV2 can move through multiple endosomal domains within the same cell. The dose-dependent movement of rAAV2 through the Rab7 and Rab11 endosomal compartments is also consistent with changes in the rate of rAAV2 transduction at increasing m.o.i. (Fig. 6) . Our findings, which demonstrate that rAAV2 preferentially traffics to, and is more efficiently processed in, the Rab11 compartment at higher m.o.i. of infection, help to explain these dosedependent effects on rAAV2 transduction.
Our functional studies using Rab siRNA's suggest that rAAV2 movement through the Rab7 and Rab11 endosomal compartments has different efficiencies of processing rAAV to express an encoded transgene. Although both inhibition of Rab11 and Rab7 reduced transduction with rAAV2, based on the number of particles that resided in each of these compartments, the level of inhibition with Rab11 siRNA was~100-fold greater than that with Rab7 siRNA on a per genome basis. Our studies demonstrating inhibition of transduction with Rab7 siRNA are consistent with previous findings that bafilomycin A1 (which inhibits late endosome acidification) also reduced transduction [8] [9] [10] 15] .
Previous studies have demonstrated that similar phenotypes on vesicular sorting can result from overexpression or siRNA inhibition of the same Rab effector protein [24] . This was indeed the case for Rab7, but not Rab11. Overexpressing wt Rab7 inhibited rAAV2 transduction by 50%. We noted in our studies that overexpression of Rab7 leads to the generation of larger late endosomes consistent with enhanced multivesicular body (MBV) formation. This compartment in the cell may ineffectively process rAAV2, and either wt Rab7 overexpression or Rab7 siRNA may lead to enhanced MBV formation. Indeed bafilomycin A1 has been also shown to prevent late biogenesis of MVBs to lysosomes [25] and is consistent with our results demonstrating that both Rab7 siRNA and overexpression of Rab7 reduced rAAV2 transduction at low m.o.i. The lack of a functional effect on rAAV2 transduction in the presence of overexpressed wt Rab11 at low m.o.i. suggests that Rab11 and/or its activation pathway may not be limiting in HeLa cells when small amounts of virus traffic through this compartment. However, at higher m.o.i., Rab11 overexpression significantly enhanced rAAV2 transduction, suggesting that under conditions under which the majority of virus traffics through the Rab11 compartment, Rab11 effector function may become limiting.
Cumulatively, the use of four complementary Rabdependent assays discussed in this article (immunoisolation, localization, siRNA Rab inhibition, and Rab overexpression) provides strong evidence for dosedependent trafficking through the Rab7 and Rab11 compartments. Taking into account the efficiencies of the immunoisolation procedure, we estimate that virus within the Rab7 and Rab11 compartments accounts for approximately 10% of intracellular genomes at low and high m.o.i. Given that the time points analyzed were relatively early following infection (30 min), the majority of the virus could remain in alternative earlier compartments. However, localization studies of Cy3-rAAV2 and each of the EGFP-tagged RabTs suggest that this may be a low estimate. At the low m.o.i., approximately 58 and 21% of rAAV localized to the Rab7 and the Rab11 compartment, respectively. This accounted for approximately 79% of intracellular virions. In contrast, at the high m.o.i. this partitioning was reversed; 57 and 25% of rAAV localized to the Rab11 and the Rab7 compartment, respectively, accounting for 82% of intracellular virions. Given the larger differences in Rab7 vs Rab11 endosomal genome content seen by immunoisolation at the two m.o.i., these findings point out an important limitation to imaging approaches, in that localization studies cannot determine the number of virions in a given compartment. However, these imaging results do suggest that the majority of AAV virions remain within the Rab7 and Rab11 compartments at 30 min postinfection.
In summary, our findings demonstrate that rAAV2 has the ability to traffic through multiple intracellular compartments in a dose-dependent fashion. The use of Rab siRNA's and Rab overexpression suggests that enhancing rAAV2 trafficking to the Rab11 compartment, or inhibiting trafficking to the Rab7 compartment, may be an effective approach to enhancing rAAV2 transduction. These approaches may also be useful for dissecting the basis of cell-specific differences in transduction with other AAV serotypes.
METHODS
Cell culture, viral infection, and endosome preparation by gradient fractionation. HeLa cells were grown in 150-mm plates in DMEM with 10% fetal bovine serum (FBS) to a density of 80% confluence. HeLa cells were cultured in DMEM containing 2% FBS for 24 h prior to infection with AV2Luc [21] or AV2FVIII [22] . Vectors were diluted in 2% FBS DMEM supplemented with 10 mM Hepes at different vector doses as discussed under Results. HeLa cells were infected by incubating the cells with a given dose of virus at 48C for 60 min and then shifting the cells to 378C for an additional 30 min in the continued presence of virus in the medium. This infection protocol allowed for a more synchronous wave of viral movement through the cell. The infected HeLa cells were harvested by a brief trypsinization, followed by scraping into precooled (48C) homogenization buffer (0.25 M sucrose, 10 mM triethanolamine, 1 mM EDTA, 1 mM PMSF, and 100 Ag/ml aprotinin). Cell numbers were quantified at this time to calculate the effective m.o.i., and then the cells were homogenized on ice with a tight-fitting Dual tissue grinder. (The percentage of denucleated cells was estimated to be 60 to 80% by monitoring with a phase-contrast microscope.) Intact cells, nuclei, and large cell debris were removed by low-speed centrifugation at 48C (800g for 10 min). The resultant PNS was adjusted to 32% iodixanol using a 60% stock solution of OptiPrep iodixanol (Nycomed, Oslo, Norway). A 1.5-ml PNS sample was bottom-loaded to a preformed iodixanol gradient (2 ml of 24% iodixanol in homogenization buffer and 1.5 ml of 20% iodixanol) in an SW55Ti centrifugation tube. The tube was filled with approximately 0.4 ml homogenization buffer to cover the top of the gradient. The gradients were then subjected to centrifugation at 124,000g (30,500 rpm when using a Beckman 7000 ultracentrifuge with a SW55Ti rotor) for 1 h at 48C. After centrifugation, the fractions were collected at 48C from the top of the gradient using a peristaltic pump connected to a fraction collector. Each fraction was set to 0.5 ml for collection, and a total of 11 fractions were collected for each centrifugation sample.
The substrate for the detection of glucosaminidase ( p-nitrophenyl-Nacetyl-h-d-glucosaminide) was purchased from Sigma, and the assay was performed following standard procedures. Briefly, 25-Al collected fraction samples were mixed with 200 Al of 1 mM p-nitrophenyl N-acetyl-h-dglucosamine in 0.05 M citrate buffer (pH 4.5) with 0.5% Triton X-100 for 6 h at 378C, and the absorbance at 410 nm was quantified as an index of enzymatic activity.
Immunoisolation of intracellular compartments. In-frame HA fusions to the N-terminus of Rab7 [19] and Rab11 [14] cDNAs were generated by PCR and cloned into a CMV expression plasmid pCMVlink (Chiron, Emeryville, CA, USA). The human Rab7 and Rab11 cDNAs were kind gifts from Drs. Bucci and Prekeris, respectively. HeLa cells were transfected with 100 Ag HA-Rab7 or HA-Rab11 expression plasmid at 80% confluence by calcium phosphate precipitation overnight. The transfected cells were cultured for an additional 48 h before being subjected to AAV infection and fractionation. Immunoisolation was then performed to enrich for Rab7 or Rab11 endosomes. Briefly, Dynabeads M-500 Subcellular (Dynal, Oslo, Norway) were resuspended thoroughly and washed in PBS. Goat anti-rat antibody (The Jackson Laboratory) was conjugated to Dynabeads at the concentration of 10 Ag/10 7 beads in 0.1 M borate buffer (pH 9.5) for 24 h at 378C with slow rotating. The beads were then placed into a magnet to remove the supernatant and were washed once in 0.1% (w/v) BSA/PBS for 5 min at 48C. The beads were then resuspended into 0.1% (w/v) BSA/0.25 mM Tris (pH 8.5) and rotated for 24 h at room temperature to block the uncoated surfaces. Blocked beads were then washed twice, resuspended in 0.1% (w/v) BSA/PBS, and conjugated to primary anti-HA antibody (10 Ag/10 7 beads) overnight at 48C. The beads were washed in BSA/PBS following conjugation. The peak vesicular fractions (300 Al) from iodixanol gradients were then mixed with 700 Al coated beads in buffer A (2 mM EDTA, 5% BSA in PBS) and incubated for 6 h at 48C with slow rocking. After immunoabsorption, the beads were captured in a magnet and washed four times for 15 min each with buffer A. Finally, beads bound with HA-Rab-enriched endosomes were resuspended in PBS for Western blotting and TaqMan-PCR for viral genomes. Western blotting antibodies used to detect Rab7 and Rab11 were purchased from BD Biosciences (San Jose, CA, USA). Control beads were conjugated with only the secondary antibody and were subjected to immunoisolation procedures in parallel with other experimental groups. No detectable Rab7 or Rab11 signal was seen by Western blotting with these control samples (data not shown).
Quantitative analysis of AAV genome by real-time PCR. AAV-containing endosome fractions were subjected to overnight digestion by nucleasefree proteinase K (10 Ag/ml) at 558C. Digestion was terminated by boiling for 10 min. PCR primers and the TaqMan probe for detecting AV2Luc were designed by Primer Express version 1.5 (PE Applied Biosystems, Foster City, CA, USA). The forward primer, P1 (5V-TTTTTGAAGCGAAGGTTGTGG-3V), and the reverse primer, P2 (5V-CACACACAGTTCGCCTCTTTG-3V), were designed to amplify a 32-bp fragment in the promoter region of AV2Luc DNA. The TaqMan probe (5V-ATCTGGATACCGGGAAAACGCTGGGCGTTAAT-3V) was designed following the general principle outlined by the manufacturer. The TaqMan probe synthesized by Genosys (Woodlands, TX, USA) was tagged with 6-carboxy fluorescein (FAM) at the 5V end as the reporter and with 6-carboxy tetramethyl rhodamine (TAMRA) at the 3V end as the quencher. The primers and detection probe for AAV2 factor VIII vector were designed as follows: forward, 5V-AAATGGATGTGGTQ CAGGTTTGAT-3V; reverse, 5V-TGTACCCAAGTTTTAGGATGCTTCT-3V; and probe, 5V-(FAM)-ATGACAACTCTCCTTCCTTTATCCAAATTCGCT-(TAMRA)-3V. The 25-Al PCR mixture consisted of 10 Al AV2Luc gradient sample, primers P1 and P2 (final concentration 500 nM), TaqMan probe (final concentration 100 nM), and 12.5 Al TaqMan Universal Master Mix (PE Applied Biosystems). The PCR was performed using the ABI Prism 7700 sequence detector system (PE Applied Biosystems). The reaction condition was set as 1 cycle at 958C for 10 min and followed by a twostep PCR procedure consisting of 15 s at 958C and 1 min at 608C for 40 cycles. All standard dilutions, controls, and unknown samples from the subcellular fractionation were run in triplicate, and the average value of the copy number was calculated according to a standard AAV2 vector dilution series. A standard curve for AV2Luc was accepted as linear when the slope fell between À3.74 and À3.32 and the coefficient of correlation was above 0.99.
AAV labeling and fluorescence microscopy. The AV2Luc viral stock was purified by standard protocols as previously described [21] and stored at 5 Â 10 11 viral particles in 5% glycerol-Hepes buffer with an additional 1 mmol/L CaCl 2 and 1 mmol/L MgCl 2 at À808C. AAV2 aliquots were thawed on ice and resuspended in 1 ml of PBS. AAV2 stocks were then cleared by centrifugation and concentrated to 50 Al in a Centricon-100 (Millipore Corp., Bedford, MA, USA). The concentrated virus was then resuspended in 500 Al conjugation buffer (0.1 M sodium carbonate, pH 9.3), incubated at room temperature for 30 min with 50 nmol/L FluoroLink monovalent Cy3 reactive dye (Amersham Pharmacia Biotech, Piscataway, NJ, USA), and thoroughly mixed every 10 min. The reaction was stopped by adding 1 ml of 10 mM Tris (pH 8.0) to the solution. The labeled virus was then dialyzed against five changes of PBS at 48C for 2 days. Finally, the Cy3-labeled virus was concentrated with a Centricon-30 (Millipore Corp.) to a final concentration of 5 Â 10 11 particles/ml. EGFP-Rab11 and EGFP-Rab7 plasmids were generously provided by Dr. Zerial (European Molecular Biology Laboratory, Germany). Rab11 or Rab7 was fused in-frame to the C-terminus of EGFP using a pCMVEGFP-C3 vector. HeLa cells grown to 50% confluence on chamber cell slides were transfected with EGFP-Rab11 or EGFP-Rab7 expression plasmids using Lipofectamine 2000 reagent (Life Technologies, Gaithersburg, MD, USA) following the manufacturerTs instructions. Twenty-four hours after transfection, the HeLa cells were precooled at 48C for 10 min and subsequently incubated with Cy3-labeled AV2Luc at 48C for 1 h at an effective m.o.i. of 100 or 10000 viral genomes/cell. Endocytosis of the virus was initiated by shifting the cells to 378C for 30 min in the continued presence of viral inoculum in the medium. Following infection, cells were washed with icecold PBS four times and then briefly treated with ice-cold 0.5 AM nocodazole in DMEM without FBS for 10 min on ice. This nocodazole treatment allowed for a more uniform dispersion of vesicles within the cells by which to quantify colocalization with Cy3-AAV2. Cells were then fixed in 4% paraformaldehyde and mounted with Vecta-Shield mounting medium. The slides were then examined with a Yokogawa CSU10 confocal microscope. Digital images were acquired with OpenLab version 3.1 software under a Leica 63Â NA 1.4 oil objective.
Quantification of colocalization of EGFP-RabTs and Cy3-labeled rAAV2. The numbers of Cy3 (red) and EGFP (green) vesicles were counted independently within the red/green channel for each cell and the overlapping yellow signal was scored using 10% threshold with NIH Image version 1.62 (i.e., any vesicle that had either the red or the green channel signal that contributed to more than 10% of the total combined red and green intensity was considered colocalized). Twenty-four individual cells were analyzed for each experimental group, and all vesicles within a given cell were quantified. Statistical analysis was performed using the Newman method.
Modulating Rab protein abundance in HeLa cells. Two approaches were used to modulate Rab7 and Rab11 protein abundance and study the resulting effects on rAAV2 transduction. These included overexpression of wild-type RabTs and the use of siRNA to inhibit endogenous RabTs. The siRNA oligo duplexes to specific human Rab proteins (sc-29460, hRab7 siRNA gene silencer; sc-36340, hRab11 siRNA gene silencer) were purchased from Santa Cruz Biotechnologies. A scrambled siRNA (sc-37007) that has been shown not to affect any known human genes was used as the negative experimental control. HeLa cells were seeded in a six-well plate at 40-50% confluence and cultured in DMEM with 10% FBS for 24 h. The cells were then transfected with siRNA's following standard protocols suggested by the manufacturer using Transfection Medium (sc-36868). HeLa cells were washed with 1Â PBS, and then the siRNA transfection mixture was applied. After the cells were cultured at 378C for 6 h, the medium was replaced by normal growth medium and cells were cultured for an additional 24 h. Using fluorescently labeled oligos, the transfection efficiency was approximately 80-90%. Half of the transfected cells were lysed by RIPA buffer and subjected to Western blotting at this time to assess the level of Rab inhibition. The blotted filters were scanned using an Odyssey 2 infrared scanner from Li-cor Biosciences, Inc. (Lincoln, NE, USA). The level of siRNA-mediated Rab inhibition was determined with bundled quantification software and normalized to h-actin levels in the same sample. The other half of the siRNA-transfected cells were infected with AV2Luc at an effective m.o.i. of 100 genomes/cell. Twenty-four hours postinfection, luciferase activity was assayed using a TD20/20 luminometer.
Studies assessing the functional consequences of wild-type Rab7 and Rab11 overexpression were performed using HA-Rab7 and HA-Rab11 plasmid expression constructs. HeLa cells were seeded on 12-well tissue culture plates at 1 Â 10 5 cells per well in DMEM with 10% FBS. The cells were then incubated for 24 h, at which time they reached 70-80% confluency. Plasmid transfections were performed with Lipofectamine 2000 using standard protocols by the manufacturer. Negative control (mock) transfections used a CMV-eGFP expression plasmid, and approximately 50% transfection was achieved in these studies. At 48 h posttransfection, cells were infected with AV2Luc by prebinding the virus to the cells at 48C for 1 h, followed by shifting the cells to 378C for 30 min to allow for viral endocytosis. Then the virus-containing medium was removed and the cells were washed once with medium. The infected cells were incubated for an additional 24 h and luciferase assays were performed.
